<?xml version="1.0" encoding="UTF-8"?>
<p id="p0200">Acceleration of development time and reduction of costs are paramount to future vaccinology for the global population. Global collaborations and data sharing are critical for fast progress, and in-depth knowledge of key viral families and platform vaccine technologies can accelerate product development for new diseases. Abundant preexisting research on coronavirus speeds up the development towards control and vaccination for COVID-19, and robust basic research is instrumental for adequate preparedness.</p>
